The Gut-Joint Connection: Microbiome's Role in Rheumatic Disease

Area of Science:

• Immunology
• Microbiology
• Rheumatology

Background:

• The human gut microbiome plays a critical role in regulating systemic immunity.
• Microbial imbalances (dysbiosis) are linked to the development and progression of rheumatic diseases via the gut-joint axis.
• Increased intestinal permeability allows microbial products to enter circulation, driving chronic inflammation.

Purpose of the Study:

• To explore the mechanisms connecting the gut microbiome to autoimmune responses in rheumatic diseases.
• To discuss the potential of targeting the gut-joint axis for therapeutic interventions.
• To review emerging microbial biomarkers for conditions like rheumatoid arthritis and lupus.

Main Methods:

• Review of existing literature on gut microbiome, immunity, and rheumatic diseases.
• Analysis of mechanisms including increased intestinal permeability and immune cell imbalance (Th17/Treg).
• Identification of specific microbial signatures associated with rheumatoid arthritis and systemic lupus erythematosus.

Main Results:

• Dysbiosis disrupts the gut-joint axis, contributing to autoimmune pathogenesis.
• Leaky gut facilitates microbial translocation and systemic inflammation.
• Specific bacteria like Prevotella copri (RA) and Ruminococcus gnavus (SLE) show potential as biomarkers.

Conclusions:

• The gut microbiome is a key factor in rheumatic disease development.
• Targeting gut microbiota through diet, probiotics, or FMT is a promising therapeutic strategy.
• Harnessing the gut-joint axis offers a new frontier for personalized management of rheumatic diseases.